Questionnaires: Assessment of stress and anxiety and quality of life after myocardial infarct:
* Stress score: Perceived Stress Scale-4 (PSS-4)
* Anxiety score: Generalized Anxiety Disorder-7 (GAD-7)
* Depression score: Patient Health Questionnaire-9 (PHQ-9)
* Quality of life scores: European Quality of Life-5 Dimensions (EQ-5D) and 12-Item Short-Form General Health Survey (SF-12)
Major events: Collection of information related to major events occurring since inclusion in the WAMIF study
Study summary
The WAMIF study was conducted from 2017 to 2019, including 314 patients in 30 French research centers spread across metropolitan France. It systematically collected the clinical, morphological, and biological characteristics of myocardial infarction cases affecting women under 50 years of age and assessed their short-term (in-hospital) and medium-term (12-month) prognosis. Extending the follow-up beyond 12 months for this first study would provide fundamental data for understanding and improving the care of these patients.
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
All patients who participated in the WAMIF study (research registration number with the French Ministry of Health : 2015-A01263-46 / Protocol registration with Clinical Trials NCT03073447) and wish to continue follow-up in the study.
Primary outcome measure(s)
Death from any cause — 5 to 10 years after the participation in WAMIF study Number of patient who died from any cause since their participation in WAMIF study
Cardiovascular death — 5 to 10 years after the participation in WAMIF study Number of patient who died from cardiovascular cause since their participation in WAMIF study
Stent thrombosis — 5 to 10 years after the participation in WAMIF study Number of patient who had stent thrombosis since their participation in WAMIF study
Stroke — 5 to 10 years after the participation in WAMIF study Number of patient who had stroke since their participation in WAMIF study
Recurrent myocardial infarct — 5 to 10 years after the participation in WAMIF study Number of patient who had recurrent myocardial infarct since their participation in WAMIF study
Emergency revascularization — 5 to 10 years after the participation in WAMIF study Number of patient who had emergency revascularization since their participation in WAMIF study
Major bleeding — 5 to 10 years after the participation in WAMIF study Number of patient who had since major bleeding their participation in WAMIF study
Emergency hospitalization for heart failure — 5 to 10 years after the participation in WAMIF study Number of patient who had emergency hospitalization for heart failure since their participation in WAMIF study
Emergency department visit — 5 to 10 years after the participation in WAMIF study Number of patient who went to emergency department since their participation in WAMIF study
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.